Xcout IntelCombined Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Combined Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Combined Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Combined Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Combined Therapeutics, Inc.
Combined Therapeutics is a biotechnology company that develops next-generation mRNA vaccines and immunotherapies for infectious diseases and oncology. The company utilizes a proprietary mRNA platform featuring microRNA binding sequences to target therapeutic protein expression in specific tissues while protecting vital organs from off-target effects.
Combined Therapeutics, Inc. at a glance
Combined Therapeutics, Inc. is a biotechnology company headquartered in United States. Its most recent funding round, Early Funding, closed in March 2023. Xcout tracks 8 named people at Combined Therapeutics, Inc., including Carol Walton (Chief Business Development Officer).
Combined Therapeutics, Inc. leadership
- Carol WaltonChief Business Development Officer
- Romain MicolPresident and Chief Executive Officer (co-founder), Board Director
- Dan AndersonCo-founder
- Robert LangerCo-founder
- Valerie DuvalDirector, Molecular Biology and mRNA Platform Development
- Paul WottonBoard Director
2 more named people on record for Combined Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Combined Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Early Funding | Undisclosed | — | |
| Series A | $20M | — | |
| SEC Form D filing | $250,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Combined Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Combined Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Xanadu Bio, Inc. is a biotechnology company that develops next-generation polymer nanoparticle delivery platforms for mRNA and other nucleic acid-based therapies. Utilizing its proprietary poly(amine-co-ester) (PACE) polymer technology, the company creates tunable, organ-specific treatments for oncology and immunology, as well as intranasal vaccines for viral respiratory pathogens.
Similar biotechnology company
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Similar biotechnology company
CHARM Therapeutics Inc. is a biopharmaceutical company utilizing proprietary technology platforms for drug discovery and therapeutic pipeline development.
Similar biotechnology company
HelixNano is a biotechnology research company headquartered in Boston, Massachusetts, focused on developing advanced mRNA platform technologies for therapeutics.
Similar biotechnology company
RNAV8 Bio is a biotechnology research company focused on renovating mRNA function through structure, chemistry, and delivery.
Similar biotechnology company
Catena Biosciences is a biotechnology company based in Berkeley, California, that pioneers protein conjugation technologies for novel therapeutics. Founded in 2020, the company builds upon technology developed in labs at the University of California, Berkeley.
Similar biotechnology company
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Biotech
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Biotech
Nosis Biosciences develops receptor-targeted RNA medicines utilizing its proprietary AI-powered platform, Connexa, which combines physics-aware deep learning, single cell biology, and high-throughput chemistry. The company's platform designs gene-silencing therapeutics intended to treat chronic conditions across various cell types and organ systems, including the heart, lungs, kidneys, and brain.
Similar biotechnology company
Congruence Therapeutics is a clinical-stage biotechnology company located in Montreal, Quebec, that discovers and develops small molecule correctors and allosteric modulators for protein-misfolding diseases.
Biotech
Remix Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts. The company specializes in developing novel therapies that alter RNA processing to address serious diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Combined Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Combined Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →